MobiHealth News May 14, 2024
The Delaware-based company provides self-insured employers with data and strategies to reduce costs associated with prescription medications.
Truveris, a health technology company focused on decreasing prescription costs for employers and their members, announced it had secured $15 million in Series E investment.
Existing investors Canaan Partners and New Leaf Venture Partners led the round.
WHAT IT DOES
The company provides technology to help employers secure lower drug pricing plans. Its software also allows sponsors to garner data-driven insights to reduce prescription costs, improve pharmacy benefit manager-contract terms and increase medication access.
The funds will be used to support the company’s operational growth.
“There has never been more attention placed on PBM practices and the impact on pharmacy...